APO Research
Talk to an analyst

APO RESEARCH · REPORT

Women’s Health Diagnostics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Women’s Health Diagnostics Market Outlook and Growth Opportunities 2026

20 December 2025191 pages

Choose your research edition.

Industry ResearchWomen’s Health Diagnostics Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Women’s Health Diagnostics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Women’s Health Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Women’s Health Diagnostics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Women’s Health Diagnostics Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Women’s Health Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Women’s Health Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Women’s Health Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Women’s Health Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Women’s Health Diagnostics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Women’s Health Diagnostics market include Siemens, Roche, Philips, Quest Diagnostics Inc., Perkinelmer Inc., Hologic, Inc., GE Healthcare, Biomerieux SA and Becton, Dickinson and Company, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Women’s Health Diagnostics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Women’s Health Diagnostics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Women’s Health Diagnostics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Women’s Health Diagnostics market.

Women’s Health Diagnostics Segment by Company

Siemens

Roche

Philips

Quest Diagnostics Inc.

Perkinelmer Inc.

Hologic, Inc.

GE Healthcare

Biomerieux SA

Becton, Dickinson and Company

Alere Inc.

Abbott Laboratories

Women’s Health Diagnostics Segment by Type

Diagnostic Devices

Diagnostic Tests

Women’s Health Diagnostics Segment by Application

Infectious Disease Testing

Osteoporosis Testing

Pregnancy and Fertility Testing

Breast Cancer

Sexually Transmitted Disease Testing

Others

Women’s Health Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Women’s Health Diagnostics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Women’s Health Diagnostics key companies, revenue, market share, and recent developments.

3. To split the Women’s Health Diagnostics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Women’s Health Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Women’s Health Diagnostics significant trends, drivers, influence factors in global and regions.

6. To analyze Women’s Health Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women’s Health Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Women’s Health Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women’s Health Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Women’s Health Diagnostics industry.

Chapter 3: Detailed analysis of Women’s Health Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Women’s Health Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Women’s Health Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Women’s Health Diagnostics Industry Trends Table 2. Women’s Health Diagnostics Industry Drivers Table 3. Women’s Health Diagnostics Industry Opportunities and Challenges Table 4. Women’s Health Diagnostics Industry Restraints Table 5. Global Women’s Health Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Women’s Health Diagnostics Revenue Share by Company (2021-2026) Table 7. Global Women’s Health Diagnostics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Women’s Health Diagnostics Key Company Manufacturing Base & Headquarters Table 9. Global Women’s Health Diagnostics Company, Product Type & Application Table 10. Global Women’s Health Diagnostics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Women’s Health Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Diagnostic Devices Table 15. Significant Companies of Diagnostic Tests Table 16. Global Women’s Health Diagnostics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Women’s Health Diagnostics Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Women’s Health Diagnostics Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Women’s Health Diagnostics Sales Value Share by Type (2021-2026) Table 20. Global Women’s Health Diagnostics Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Infectious Disease Testing Table 22. Significant Companies of Osteoporosis Testing Table 23. Significant Companies of Pregnancy and Fertility Testing Table 24. Significant Companies of Breast Cancer Table 25. Significant Companies of Sexually Transmitted Disease Testing Table 26. Significant Companies of Others Table 27. Global Women’s Health Diagnostics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Women’s Health Diagnostics Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Women’s Health Diagnostics Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Women’s Health Diagnostics Sales Value Share by Application (2021-2026) Table 31. Global Women’s Health Diagnostics Sales Value Share by Application (2027-2032) Table 32. Global Women’s Health Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Women’s Health Diagnostics Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Women’s Health Diagnostics Sales Value Share by Region (2021-2026) Table 35. Global Women’s Health Diagnostics Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Women’s Health Diagnostics Sales Value Share by Region (2027-2032) Table 37. Global Women’s Health Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Women’s Health Diagnostics Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Women’s Health Diagnostics Sales Value Market Share by Country (2021-2026) Table 40. Global Women’s Health Diagnostics Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Women’s Health Diagnostics Sales Value Market Share by Country (2027-2032) Table 42. Siemens Company Information Table 43. Siemens Business Overview Table 44. Siemens Women’s Health Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Siemens Women’s Health Diagnostics Product Portfolio Table 46. Siemens Recent Development Table 47. Roche Company Information Table 48. Roche Business Overview Table 49. Roche Women’s Health Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Roche Women’s Health Diagnostics Product Portfolio Table 51. Roche Recent Development Table 52. Philips Company Information Table 53. Philips Business Overview Table 54. Philips Women’s Health Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Philips Women’s Health Diagnostics Product Portfolio Table 56. Philips Recent Development Table 57. Quest Diagnostics Inc. Company Information Table 58. Quest Diagnostics Inc. Business Overview Table 59. Quest Diagnostics Inc. Women’s Health Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Quest Diagnostics Inc. Women’s Health Diagnostics Product Portfolio Table 61. Quest Diagnostics Inc. Recent Development Table 62. Perkinelmer Inc. Company Information Table 63. Perkinelmer Inc. Business Overview Table 64. Perkinelmer Inc. Women’s Health Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Perkinelmer Inc. Women’s Health Diagnostics Product Portfolio Table 66. Perkinelmer Inc. Recent Development Table 67. Hologic, Inc. Company Information Table 68. Hologic, Inc. Business Overview Table 69. Hologic, Inc. Women’s Health Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Hologic, Inc. Women’s Health Diagnostics Product Portfolio Table 71. Hologic, Inc. Recent Development Table 72. GE Healthcare Company Information Table 73. GE Healthcare Business Overview Table 74. GE Healthcare Women’s Health Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. GE Healthcare Women’s Health Diagnostics Product Portfolio Table 76. GE Healthcare Recent Development Table 77. Biomerieux SA Company Information Table 78. Biomerieux SA Business Overview Table 79. Biomerieux SA Women’s Health Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Biomerieux SA Women’s Health Diagnostics Product Portfolio Table 81. Biomerieux SA Recent Development Table 82. Becton, Dickinson and Company Company Information Table 83. Becton, Dickinson and Company Business Overview Table 84. Becton, Dickinson and Company Women’s Health Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Becton, Dickinson and Company Women’s Health Diagnostics Product Portfolio Table 86. Becton, Dickinson and Company Recent Development Table 87. Alere Inc. Company Information Table 88. Alere Inc. Business Overview Table 89. Alere Inc. Women’s Health Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Alere Inc. Women’s Health Diagnostics Product Portfolio Table 91. Alere Inc. Recent Development Table 92. Abbott Laboratories Company Information Table 93. Abbott Laboratories Business Overview Table 94. Abbott Laboratories Women’s Health Diagnostics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Abbott Laboratories Women’s Health Diagnostics Product Portfolio Table 96. Abbott Laboratories Recent Development Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Women’s Health Diagnostics Product Image Figure 2. Global Women’s Health Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 4. Global Women’s Health Diagnostics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Diagnostic Devices Image Figure 8. Diagnostic Tests Image Figure 9. Global Women’s Health Diagnostics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Women’s Health Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Women’s Health Diagnostics Sales Value Share by Type (2021-2032) Figure 12. Infectious Disease Testing Image Figure 13. Osteoporosis Testing Image Figure 14. Pregnancy and Fertility Testing Image Figure 15. Breast Cancer Image Figure 16. Sexually Transmitted Disease Testing Image Figure 17. Others Image Figure 18. Global Women’s Health Diagnostics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Women’s Health Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Women’s Health Diagnostics Sales Value Share by Application (2021-2032) Figure 21. Global Women’s Health Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Women’s Health Diagnostics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Women’s Health Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 24. North America Women’s Health Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Women’s Health Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Women’s Health Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Women’s Health Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Women’s Health Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Women’s Health Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 30. South America Women’s Health Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Women’s Health Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Women’s Health Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Women’s Health Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Devices
  • Diagnostic Tests
Applications
  • Infectious Disease Testing
  • Osteoporosis Testing
  • Pregnancy and Fertility Testing
  • Breast Cancer
  • Sexually Transmitted Disease Testing
  • Others
Companies covered
  • Siemens
  • Roche
  • Philips
  • Quest Diagnostics Inc.
  • Perkinelmer Inc.
  • Hologic, Inc.
  • GE Healthcare
  • Biomerieux SA
  • Becton, Dickinson and Company
  • Alere Inc.
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Women’s Health Diagnostics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Women’s Health Diagnostics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Women’s Health Diagnostics Market Dynamics
  1. 2.1 Women’s Health Diagnostics Industry Trends
  2. 2.2 Women’s Health Diagnostics Industry Drivers
  3. 2.3 Women’s Health Diagnostics Industry Opportunities and Challenges
  4. 2.4 Women’s Health Diagnostics Industry Restraints
3 Women’s Health Diagnostics Market by Company
  1. 3.1 Global Women’s Health Diagnostics Company Revenue Ranking in 2025
  2. 3.2 Global Women’s Health Diagnostics Revenue by Company (2021-2026)
  3. 3.3 Global Women’s Health Diagnostics Company Ranking (2024-2026)
  4. 3.4 Global Women’s Health Diagnostics Company Manufacturing Base and Headquarters
  5. 3.5 Global Women’s Health Diagnostics Company Product Type and Application
  6. 3.6 Global Women’s Health Diagnostics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Women’s Health Diagnostics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Women’s Health Diagnostics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Women’s Health Diagnostics Market by Type
  1. 4.1 Women’s Health Diagnostics Type Introduction
  2. 4.1.1 Diagnostic Devices
  3. 4.1.2 Diagnostic Tests
  4. 4.2 Global Women’s Health Diagnostics Sales Value by Type
  5. 4.2.1 Global Women’s Health Diagnostics Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Women’s Health Diagnostics Sales Value by Type (2021-2032)
  7. 4.2.3 Global Women’s Health Diagnostics Sales Value Share by Type (2021-2032)
5 Women’s Health Diagnostics Market by Application
  1. 5.1 Women’s Health Diagnostics Application Introduction
  2. 5.1.1 Infectious Disease Testing
  3. 5.1.2 Osteoporosis Testing
  4. 5.1.3 Pregnancy and Fertility Testing
  5. 5.1.4 Breast Cancer
  6. 5.1.5 Sexually Transmitted Disease Testing
  7. 5.1.6 Others
  8. 5.2 Global Women’s Health Diagnostics Sales Value by Application
  9. 5.2.1 Global Women’s Health Diagnostics Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Women’s Health Diagnostics Sales Value by Application (2021-2032)
  11. 5.2.3 Global Women’s Health Diagnostics Sales Value Share by Application (2021-2032)
6 Women’s Health Diagnostics Regional Value Analysis
  1. 6.1 Global Women’s Health Diagnostics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Women’s Health Diagnostics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Women’s Health Diagnostics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Women’s Health Diagnostics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Women’s Health Diagnostics Sales Value (2021-2032)
  7. 6.3.2 North America Women’s Health Diagnostics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Women’s Health Diagnostics Sales Value (2021-2032)
  10. 6.4.2 Europe Women’s Health Diagnostics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Women’s Health Diagnostics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Women’s Health Diagnostics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Women’s Health Diagnostics Sales Value (2021-2032)
  16. 6.6.2 South America Women’s Health Diagnostics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Women’s Health Diagnostics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Women’s Health Diagnostics Sales Value Share by Country, 2025 VS 2032
7 Women’s Health Diagnostics Country-level Value Analysis
  1. 7.1 Global Women’s Health Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Women’s Health Diagnostics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Women’s Health Diagnostics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Women’s Health Diagnostics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Women’s Health Diagnostics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Women’s Health Diagnostics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Women’s Health Diagnostics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Siemens
  2. 8.1.1 Siemens Company Information
  3. 8.1.2 Siemens Business Overview
  4. 8.1.3 Siemens Women’s Health Diagnostics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Siemens Women’s Health Diagnostics Product Portfolio
  6. 8.1.5 Siemens Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Women’s Health Diagnostics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Women’s Health Diagnostics Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Philips
  14. 8.3.1 Philips Company Information
  15. 8.3.2 Philips Business Overview
  16. 8.3.3 Philips Women’s Health Diagnostics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Philips Women’s Health Diagnostics Product Portfolio
  18. 8.3.5 Philips Recent Developments
  19. 8.4 Quest Diagnostics Inc.
  20. 8.4.1 Quest Diagnostics Inc. Company Information
  21. 8.4.2 Quest Diagnostics Inc. Business Overview
  22. 8.4.3 Quest Diagnostics Inc. Women’s Health Diagnostics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Quest Diagnostics Inc. Women’s Health Diagnostics Product Portfolio
  24. 8.4.5 Quest Diagnostics Inc. Recent Developments
  25. 8.5 Perkinelmer Inc.
  26. 8.5.1 Perkinelmer Inc. Company Information
  27. 8.5.2 Perkinelmer Inc. Business Overview
  28. 8.5.3 Perkinelmer Inc. Women’s Health Diagnostics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Perkinelmer Inc. Women’s Health Diagnostics Product Portfolio
  30. 8.5.5 Perkinelmer Inc. Recent Developments
  31. 8.6 Hologic, Inc.
  32. 8.6.1 Hologic, Inc. Company Information
  33. 8.6.2 Hologic, Inc. Business Overview
  34. 8.6.3 Hologic, Inc. Women’s Health Diagnostics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hologic, Inc. Women’s Health Diagnostics Product Portfolio
  36. 8.6.5 Hologic, Inc. Recent Developments
  37. 8.7 GE Healthcare
  38. 8.7.1 GE Healthcare Company Information
  39. 8.7.2 GE Healthcare Business Overview
  40. 8.7.3 GE Healthcare Women’s Health Diagnostics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GE Healthcare Women’s Health Diagnostics Product Portfolio
  42. 8.7.5 GE Healthcare Recent Developments
  43. 8.8 Biomerieux SA
  44. 8.8.1 Biomerieux SA Company Information
  45. 8.8.2 Biomerieux SA Business Overview
  46. 8.8.3 Biomerieux SA Women’s Health Diagnostics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Biomerieux SA Women’s Health Diagnostics Product Portfolio
  48. 8.8.5 Biomerieux SA Recent Developments
  49. 8.9 Becton, Dickinson and Company
  50. 8.9.1 Becton, Dickinson and Company Company Information
  51. 8.9.2 Becton, Dickinson and Company Business Overview
  52. 8.9.3 Becton, Dickinson and Company Women’s Health Diagnostics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Becton, Dickinson and Company Women’s Health Diagnostics Product Portfolio
  54. 8.9.5 Becton, Dickinson and Company Recent Developments
  55. 8.10 Alere Inc.
  56. 8.10.1 Alere Inc. Company Information
  57. 8.10.2 Alere Inc. Business Overview
  58. 8.10.3 Alere Inc. Women’s Health Diagnostics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Alere Inc. Women’s Health Diagnostics Product Portfolio
  60. 8.10.5 Alere Inc. Recent Developments
  61. 8.11 Abbott Laboratories
  62. 8.11.1 Abbott Laboratories Company Information
  63. 8.11.2 Abbott Laboratories Business Overview
  64. 8.11.3 Abbott Laboratories Women’s Health Diagnostics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Abbott Laboratories Women’s Health Diagnostics Product Portfolio
  66. 8.11.5 Abbott Laboratories Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst